ACM
GILD icon

Anfield Capital Management’s Gilead Sciences GILD Stock Holding History

Anfield Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.02K Hold
36
– – ﹤0.01% 508
2025
Q4 		$4.42K Hold
36
– – ﹤0.01% 416
2025
Q3 		$4K Buy
36
+4
+13% +$455 ﹤0.01% 427
2025
Q2 		$3.55K Hold
32
– – ﹤0.01% 397
2025
Q1 		$3.59K Hold
32
– – ﹤0.01% 356
2024
Q4 		$2.96K Sell
32
-85
-73% -$7.65K ﹤0.01% 355
2024
Q3 		$9.81K Buy
117
+85
+266% +$6.49K ﹤0.01% 235
2024
Q2 		$2.2K Buy
+32
New +$2.14K ﹤0.01% 320

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Anfield Capital Management's GILD Position: Q1 2026 in Review

Anfield Capital Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 36 shares worth $5.02K. The position accounts for ﹤0.01% of the portfolio, ranked #508.

Anfield Capital Management first reported a position in GILD in Q2 2024 and has held it in 8 quarters since. The position peaked at $9.81K in Q3 2024. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Anfield Capital Management held 36 shares of Gilead Sciences worth $5.02K as of Q1 2026.
  • Anfield Capital Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up ﹤0.01% of Anfield Capital Management's portfolio in Q1 2026, its #508 holding.
  • Anfield Capital Management first reported a position in Gilead Sciences in Q2 2024 and has held it in 8 quarters since.
  • Anfield Capital Management's Gilead Sciences position peaked at $9.81K in Q3 2024.
  • 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.